<DOC>
	<DOCNO>NCT01066364</DOCNO>
	<brief_summary>The purpose study see drug colesevelam potential treatment Nonalcoholic Steatohepatitis ( NASH ) .</brief_summary>
	<brief_title>Colesevelam Versus Placebo Treatment Nonalcoholic Steatohepatitis</brief_title>
	<detailed_description>We plan investigate role colesevelam , bile-acid binding resin , patient NASH reside United States assess liver fat change therapy use MRI liver . It hypothesize colesevelam would lead great improvement insulin sensitivity lipid profile compare placebo may lead great improvement liver fat MRI compare placebo . In pilot study , propose randomize approximately 55 patient ( 1:1 ratio ) either colesevelam placebo treat 24-weeks evaluate change baseline insulin sensitivity , serum biochemistry ( ALT AST ) , liver fat MRI therapy . Liver histologic change would also examine exploratory outcome future study .</detailed_description>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<criteria>1 . Age entry least 18 year . 2 . Serum alanine ( ALT ) aspartate ( AST ) aminotransferase activity upper limit normal . 19 woman 30 men . 3 . Evidence hepatic steatosis liver fat ( &gt; 5 % ) MRI . 4 . Evidence definite suspect NASH 5 . Written informed consent . Exclusion criterion : 1 . Evidence another form liver disease . 2 . History excess alcohol ingestion . 3 . Contraindications liver biopsy . 4 . Decompensated liver disease . 5 . History gastrointestinal bypass surgery ingestion drug know produce hepatic steatosis . 6 . Recent initiation change antidiabetic drug . 7 . Use colesevelam agent class . 8 . Significant systemic major illness liver disease , opinion investigator would preclude treatment colesevelam adequate follow . 9 . Positive test antiHIV . 10 . Active substance abuse , alcohol , inhale injection drug within previous one year . 11 . Pregnancy inability practice adequate contraception woman childbearing potential . 12 . Evidence hepatocellular carcinoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>NASH</keyword>
	<keyword>NAFLD</keyword>
	<keyword>Steatohepatitis</keyword>
	<keyword>Nonalcoholic</keyword>
	<keyword>Fatty Liver Disease</keyword>
</DOC>